Cat: HF-2034H
Cat: HF-2034H
Dkk1, Human, HEK293 Cells,Tag Free: Product Information
26.6 kDa
Human embryonic kidney cell, HEK293-derived human Dkk1 protein
Met 2-His 266
O94907
Dickkopf-1; dickkopf-related protein 1; Dkk1; Dkk-1; hDkk-1; SKdickkopf-1 like
Solution protein
Dissolved in sterile PBS buffer .
This solution can be diluted into other aqueous buffers. Centrifuge the vial prior to opening.
Avoid repeated freeze-thaw cycles.
It is recommended that the protein be aliquoted for optimal storage.
12 months from date of receipt, -20 to -70 °C as supplied.
Shipping with dry ice
> 95%, determined by SDS-PAGE.
<0.010 EU per 1 ug of the protein by the LAL method.
Measured by its ability to inhibit Wnt induced TCF reporter activity in HEK293 human embryonic kidney cells.
The EC50 for this effect is approximately 1-8 ng/ml.
Dkk1, Human, HEK293 Cells,Tag Free:SDS-PAGE & Bioactivity
Dkk1, Human, HEK293 Cells,Tag Free:Synonyms
Dickkopf-1; dickkopf-related protein 1; Dkk1; Dkk-1; hDkk-1; SKdickkopf-1 like
Dkk1, Human, HEK293 Cells,Tag Free:Background
Dickkopf related protein 1 (Dkk-1) is the founding member of the Dickkopf family of proteins that includes Dkk-1, -2, -3, -4, and a related protein, Soggy (1, 2). Dkk proteins are secreted proteins that contain two conserved cysteine-rich domains separated by a linker region. Each domain contains ten cysteine residues (1-3). Mature human Dkk-1 is a 40 kDa glycosylated protein that shares 86%, 87%, 90% and 91% aa sequence identity with mouse, rat, rabbit and bovine Dkk-1, respectively. It also shares 42% and 36% aa identity with human Dkk-2 and Dkk-4, respectively. Dkk-1 and Dkk-4 are well documented antagonists of the canonical Wnt signaling pathway (1, 2). This pathway is activated by Wnt engagement of a receptor complex composed of the Frizzled proteins and one of two low-density lipoprotein receptor-related proteins, LRP5 or LRP6 (4). Dkk-1 antagonizes Wnt by forming ternary complexes of LRP5/6 with Kremen1 or Kremen2 (4, 5). Dkk-1/LRP6/Krm2 complex internalization has been shown to down-regulate Wnt signaling (4, 5). Dkk-1 is expressed throughout development and antagonizes Wnt-7a during limb development (6, 7). Other sites of expression include developing neurons, hair follicles and the retina of the eye (8, 9). The balance between Wnt signaling and Dkk-1 inhibition is critical for bone formation and homeostasis (10). Insufficient or excess Dkk-1 activity in bone results in increased or decreased bone density, respectively (8, 11). In adults, Dkk-1 is expressed in osteoblasts and osteocytes, and neurons. Cerebral ischemia induces Dkk-1 expression, which contributes to neuronal cell death (12)
1. Krupnik, V.E. et al. (1999) Gene 238:301.
2. Niehrs, C. (2006) Oncogene 25:7469.
3. Bullock, C.M. et al. (2004) Mol. Pharmacol. 65:582.
4. Mao, B. et al. (2001) Nature 411:321.
5. Mao, B. et al. (2002) Nature 417:664.
6. Kemp, C. et al. (2005) Dev. Dyn. 233:1064.
7. Adamska, M. et al. (2004) Dev. Biol. 272:134.
8. Li, J. et al. (2006) Bone 36:754.
9. Verani, R. et al. (2006) J. Neurochem. 101:242.
10. Pinzone, J.J. et al. (2009) Blood 113:517.
11. Morvan, F. et al. (2006) J. Bone Miner. Res. 21:934.
12. Cappuccio, I. et al. (2005) J. Neurosci. 25:2647.